Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Revenue

Vanda Pharmaceuticals had revenue of $50.53M in the quarter ending June 30, 2026, a decrease of -3.92%. This brings the company's revenue in the last twelve months to $215.72M, up 6.02% year-over-year. In the year 2025, Vanda Pharmaceuticals had annual revenue of $216.11M with 8.72% growth.

• Revenue (ttm): $215.72M
• Revenue Growth: +6.02%
• P/S Ratio: 1.49
• Revenue / Employee: $404,730
• Employees: 533
• Market Cap: 323.78M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	216.11M	17.33M	8.72%
Dec 31, 2024	198.77M	6.13M	3.18%
Dec 31, 2023	192.64M	-61.74M	-24.27%
Dec 31, 2022	254.38M	-14.30M	-5.32%
Dec 31, 2021	268.68M	20.51M	8.27%
Dec 31, 2020	248.17M	20.98M	9.23%
Dec 31, 2019	227.19M	34.07M	17.64%
Dec 31, 2018	193.12M	28.04M	16.98%
Dec 31, 2017	165.08M	19.07M	13.06%
Dec 31, 2016	146.02M	36.09M	32.83%
Dec 31, 2015	109.93M	59.77M	119.16%
Dec 31, 2014	50.16M	16.28M	48.05%
Dec 31, 2013	33.88M	1.15M	3.52%
Dec 31, 2012	32.73M	1.46M	4.66%
Dec 31, 2011	31.27M	-4.44M	-12.43%
Dec 31, 2010	35.71M	31.16M	685.16%
Dec 31, 2009	4.55M	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	-	-	-

Data Source: Fiscal.ai Last updated: Aug 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error